About

Our Science

Our Programs

Careers

Investors & Media

Stockholder Tools

Global - Contact

Investor Contact

 

Media Contact

 

News Releases

8/21/2019

Constellation Pharmaceuticals to Participate in Two Investor Conferences

8/7/2019

Constellation Pharmaceuticals Announces Second-Quarter and Six-Month 2019 Financial Results

6/13/2019

Constellation Pharmaceuticals to Present at BMO Prescriptions for Success Healthcare Conference

6/12/2019

Constellation Pharmaceuticals Presentation Highlights Enhanced EZH2 Target Engagement, Leading to Second-Generation EZH2 Inhibitor CPI-0209

6/3/2019

Interim Data for CPI-0610 in MANIFEST Clinical Trial Showed Signals of Clinical Activity in Myelofibrosis Patients

5/31/2019

Constellation Pharmaceuticals to Present at Jefferies Healthcare Conference

5/23/2019

Constellation Pharmaceuticals to Host Analyst/Investor Meeting at ASCO to Discuss Interim Update of Data of CPI-0610 in MANIFEST Clinical Trial

5/20/2019

Constellation Pharmaceuticals Presents Poster on Studies of CPI-0209 in Bladder Cancer at AACR Meeting

5/16/2019

Constellation Pharmaceuticals Provides Interim Update of Data for CPI-0610 in ASCO and EHA Abstracts

5/8/2019

Constellation Pharmaceuticals Announces First-Quarter 2019 Financial Results

4/19/2019

Constellation Pharmaceuticals to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor Day

4/1/2019

Constellation Pharmaceuticals Presents Results from Phase 1b Portion of ProSTAR Clinical Trial of CPI-1205 at AACR Meeting

3/14/2019

Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2018 Financial Results

3/6/2019

Constellation Pharmaceuticals to Present at Upcoming Investor Conference

3/4/2019

Constellation Pharmaceuticals Appoints Jessica Christo as Chief Product Development Officer

2/22/2019

Constellation Pharmaceuticals to Present at Upcoming Investor Conferences

2/20/2019

Constellation Pharmaceuticals Announces Appointment to Board of Directors

1/3/2019

Constellation Pharmaceuticals Provides Update on MANIFEST Clinical Trial of CPI-0610 in Myelofibrosis, Reviews 2018 Accomplishments, and Announces 2019 Data Disclosure Plans for Lead Programs